Wing Y. So

Hong Kong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Gene therapy targeting key beta cell regulators as a potential intervention for diabetes.

Gene therapy targeting key beta cell regulators as a potential intervention for diabetes.

Journal: EMBO molecular medicine
Published: April 16, 2024

Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy.

Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy.

Journal: EMBO molecular medicine
Published: April 28, 2023

Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model.

Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model.

Journal: Science advances
Published: November 23, 2022

IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion.

IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion.

Journal: Nature communications
Published: April 06, 2020

Paired box 6 programs essential exocytotic genes in the regulation of glucose-stimulated insulin secretion and glucose homeostasis.

Paired box 6 programs essential exocytotic genes in the regulation of glucose-stimulated insulin secretion and glucose homeostasis.

Journal: Science translational medicine
Published: January 31, 2020

Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.

Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.

Journal: Clinical science (London, England : 1979)
Published: January 29, 2019

Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.

Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.

Journal: Clinical science (London, England : 1979)
Published: July 20, 2016

Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling.

Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling.

Journal: The international journal of biochemistry & cell biology
Published: February 23, 2016

Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.

Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.

Journal: Medicinal research reviews
Published: July 21, 2015

Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.

Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.

Journal: Molecular and cellular endocrinology
Published: January 08, 2014

High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling.

High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling.

Journal: Diabetes
Published: July 31, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026